Brazil, the world's top consumer of agricultural pesticides, adopts a unique hazardbased cut-off approach to pesticide registration. Cut-off criteria for mutagenicity, carcinogenicity, teratogenicity, hormonal disturbances and damage to reproductive organs were introduced by the Pesticide Law enacted in 1989. As far as health is concerned, law enforcement is additionally regulated by rules issued by the federal health authority (National Agency for Health Surveillance -ANVISA). Contrasting to the European Union's hazard-based cut-off criteria for pesticides, Brazilian rules do not make an exception for "negligible" exposures. Moreover, Brazilian regulations have shortcomings (e.g. no reference to relevance of Mode of Action to humans) that make cut-off criteria diffi cult to be put into effect. The defi ciencies of regulations and diffi culties to consistently apply the hazard-based cut-off criteria are appraised in this article. Adoption of a risk assessment approach or cut-off criteria based on classifi cation into the Globally Harmonized System's hazard categories 1A and 1B is suggested.
Introduction
The notion that the magnitude of a toxic reaction depends on the amount of substance to which someone is exposed -or that "the dose makes the poison" -is a cornerstone principle of toxicological science. A direct corollary of this principle is the idea that there should always be a dose (exposure level) below which no toxicity occurs. To assess the risk of a chemical substance, today's toxicologists use data from animal and human studies to identify the hazard and uncover dose/exposure -toxic response relationships. The risk assessment process provides a rational basis for interventions (including regulatory decisions) aimed at protecting the population from health hazards posed by thousands of natural and man-made chemicals we have to live with in our increasingly technology-driven society 2, 3 .
Pesticide toxicity, hazard and risk
Although hazard and risk are terms commonly used by toxicologists and public health scientists, the distinction between them is not always clearly understood by non-experts.
Hazard is a source of potential harm or adverse health effect on someone that may or may not occur depending on certain conditions. Sometimes, however, the word hazard is employed to refer to the harm or adverse health effect produced rather than to its source. For instance, although a chemical carcinogen is generally considered a hazard, or a hazardous agent, its effect -cancer -might be at times called a hazard as well.
Risk, on the other hand, is a probabilistic concept. As far as toxicity is concerned, risk is the chance or probability that a person or animal will experience an adverse health effect if exposed (under certain conditions) to a chemical.
Therefore, while hazard is something or a set of circumstances that can potentially harm a person's health, risk is the likelihood (or probability) that a person will be harmed by a particular hazard.
The likelihood of developing an illness or getting injured after being exposed to a chemical agent depends on the level of exposure (actually, the internal dose received) as well as 
Consequences of hazard taking precedence over risk in decision-making
Since the likelihood that a person will be harmed by a particular hazard depends upon exposure (and some other conditions), in principle, risk (probability) and not hazard (potential to harm) should be used for guiding public health interventions. A great contribution along this line was the systematization of the risk assessment process by the US National Academy of Sciences (NAS) in the early 1980s 11 .
Therefore, when the Brazilian parliament passed the Pesticide Law in 1989 4 , a systematized approach to risk assessment was already available and was being used worldwide to support regulatory decisions on chemicals. Although the word "risk"
("risco") appears a couple of times in the law (e.g., "health and environmental risks"), it remains obscure whether it was used to refer to risk or hazard, a confusion that is often made by non-experts. At any rate, it is unclear why legislators ignored "risk assessment", a systematic, scientifi cally-based, and more rational approach to decision-making than the adopted hazard-based cut-off criteria.
It is more or less obvious that pesticides that pass the hazardbased cut-off criteria established by the law may pose a higher health risk than those that failed to do it. A number of relevant health hazards are outside the set of hazards for which cut-off criteria were introduced. More importantly, however, is that, depending on the level of exposure, a slightly to moderately hazardous chemical may turn out to be a signifi cant health risk, and vice versa, i.e., a very hazardous substance may turn out to be a negligible risk to people's health.
Some supporters of the current hazard-based cut-off criteria for pesticide registration have argued that this would never happen in Brazil because ANVISA subsequently undertakes a risk assessment for the substances that passed the initial cut-off criteria based purely on hazard. According to them, Brazil's unique regulatory approach would in fact offer greater protection against harmful effects of pesticides on people's health because, after excluding the substances that potentially cause some important adverse effects (regardless of their risks), exposure would be taken into account for risk management of the remaining ones. This is a misleading argument because it omits an important fact regarding our society's dependence on the use of pesticides and how their market is regulated. Pesticides are needed for agriculture, to control insect-borne diseases, to exterminate domestic and urban pests, to protect wood from termites, and so on.
If a particular pesticide is removed from the market (or not registered in the country) another product inevitably takes its place to fulfi ll existing agricultural or other needs. Therefore, a pre-selection based on hazard limits the number of substances available for a further selection based on risk and for choosing the best health risk management alternatives. Owing to this fact, a hazard-based selection, irrespective of whether it is followed by a risk assessment approach or not, is a bad option.
To accomplish their mission to protect people's health against harmful effects caused by pesticides, regulators have to keep one eye on the risk and the other on society's need for a particular pesticide and alternatives.
Besides not consistently excluding the pesticide compounds that pose the highest health risks, hazard-based cut-off criteria are also diffi cult to implement. The Brazilian current regulations have a number of shortcomings that make implementation of hazard-based cut-off criteria even more diffi cult, error-prone and unpredictable.
Some additional shortcomings of Brazilian hazard-based cut-off criteria
No remark on the relevance of Mode of Action to humans. As far as human health is concerned, the extent to which animal data can be extrapolated to humans is a key question for using them to put into effect a hazard-based cut-off criterion for The uncertainty regarding possible interspecies differences also holds true for teratogenicity, mutagenicity and hormonal actions. Thalidomide, for instance, is a potent human (and non-human primate) teratogen, but causes no birth defects in rats and is only a weak teratogen in rabbits 14 .
Phenobarbital and aspirin, to cite only two of many examples, are teratogenic to rats but apparently not to humans (both are among the medicines that are most often used by pregnant women; therefore, clinical information is available regarding human prenatal exposure).
At any rate, whenever feasible, kinetic similarities/ dissimilarities between test species and humans should be investigated to strengthen the predictive value of in vivo animal tests for teratogenicity, mutagenicity, carcinogenicity and hormonal actions.
The law, decree and current health authority rules on the hazard-based cut-off criteria make no comment on the relevance, to humans, of modes of action of adverse effects Since it has been agreed upon that teratogenicity is the ability to increase the incidence of malformations (but not the enhancement of variations only), occurrence of grey zone anomalies often leads to confl icting conclusions as to whether the substance is teratogenic (to the species under investigation) or not.
Unsuitability of using teratogenicity as a cut-off criterion
Another diffi culty in consistently applying a cut-off criterion to teratogenicity is the still standing controversy on the interpretation of fetal anomalies found only at maternally toxic dose levels. Some researchers think that increases in the occurrence of fetal anomalies, noted only at doses which are overtly toxic to the dams, are likely to be effects secondary to changes of maternal homeostasis and thus should not be taken as evidence of "developmental toxicity" or "teratogenicity" 18, 19 .
Other experts, including the author of this article, think that developmental toxicity is developmental toxicity irrespective of being maternally mediated or not 18 . At any rate, it is questionable to classify (label) a chemical as a teratogen Finally, it should be stressed that both controversial matters (i.e., to distinguish malformations from variations and the role of maternal toxicity) are less critical issues if a risk assessment rather than a hazard-based approach is adopted for decision-making on pesticide registration.
EU hazard-based criteria for labeling and registration of pesticides
As aforementioned, the Brazilian hazard-based cut-off criteria for pesticide registration are unique in the world. In the US, the Environmental Protection Agency (EPA) adopts a risk assessment approach to regulatory decision-making on pesticides. A hazard-based cut-off approach is employed for pesticide labeling and placing on the market in the EU 21 .
There are, however, marked differences between the cut-off criteria that have been adopted in Brazil since 1989, and those introduced in the European Union in 2009. The differences between Brazilian and European Union cut-off criteria are summarized in Table 1 .
The EU Directive 91/414, concerning the placing of plant protection products (pesticides) on the market, which entered into force on July 15 th , 1991, stipulated that active substances contained in pesticide products must be assessed regarding possible risks for humans and animals 22 More pragmatic and better scientifi cally-based defi nitions of "negligible exposure" have also been suggested, such as using the concepts of margin of exposure (MOE) or threshold of toxicological concern (TTC) 23, 24, 25 .
It is of note that EU cut-off criteria take advantage of hazard are for known or presumed human mutagens, carcinogens, and reproductive toxicants 26, 27 . Classifi cation into category 1A
is largely based on evidence obtained directly from humans, while allocation to category 1B is based on data from animal studies. In both cases the strength of evidence is taken into account for classifi catory purposes. Chemicals for which there is "some" evidence are put into Category 2 (suspected human toxicant) while those chemicals that epidemiological studies have proved to be not hazardous to humans, and those that have not been studied yet remain unclassifi ed 26, 27 . It is of note that allocation to hazard category 2 does not prevent a pesticide from being placed on the market according to EU cut-off criteria 21 . The CLP/GHS classifi cation scheme also takes into consideration other facts depending on the particular hazard category. 26, 27 .
Although still being basically a hazard-based cut-off approach, the EU decision-making process on pesticides incorporates elements of risk assessment, i.e., the idea that if exposure is very low ("negligible exposure") the substance will pose no health risk. What is to be considered a "negligible exposure", without previously assessing the risk of the substance under consideration, however, is a debatable topic and thus a weakness of the EU approach compared to the risk assessment process adopted by the US EPA.
At any rate, compared to the EU approach based on CLP/ GHS classifi cation (hazard categories 1A and 1B), the hazardbased cut-off approach currently adopted in Brazil has plenty of defi ciencies and is a worse option if the goal is to put into effect regulatory decisions on pesticides aimed at protecting public health.
Concluding remarks
Hazard-based cut-off criteria do not take into account the "level of exposure". Since the likelihood of being harmed by a chemical substance depends on exposure, approaches based only on hazard do not provide a rational basis for regulatory decisions. For guiding regulatory decisions on chemicals, health risk (probability to harm) should always take precedence over hazard (potential to harm).
Brazil adopts hazard-based cut-off criteria (mutagenicity, carcinogenicity, teratogenicity, hormonal actions) for pesticide registration 4 . Contrasting to the EU cut-off criteria for plant protection products that exempt "negligible" exposures 21 ,
the Brazilian cut-off criteria are based purely on hazard,
i.e., they do not take exposure into account. Additionally, a number of shortcomings (e.g. no clear reference to the strength of evidence and to the relevance of the Mode of Applicable if pesticide has endocrine disrupting properties that may cause adverse effects in humans § Only for carcinogenicity draft proposal rules make a remark on the relevance of the MOA to humans. The rule, however, is not entirely clear. As written (in Portuguese) the reader may misinterpret that a positive result in two animal species would trigger the cut-off for carcinogenicity even if, for both species, the MOA is shown not to be relevant to humans. The text should be rephrased to make it clearer that cut-off shall not be triggered if MOA is demonstrated not to be relevant to humans.
Action to humans) of the Pesticide Law and health authority regulations make the Brazilian cut-off criteria diffi cult to be consistently implemented. A draft proposal of a new regulation on pesticides has been recently published by ANVISA and is on the table to receive criticisms and comments 10 . As a rule, the proposed changes are not based on sound toxicological science principles and make implementation of cut-off criteria far more restrictive. This particularly holds true for proposed new rules to put into effect cut-off criteria for teratogenicity and hormonal actions. According to the draft proposal, "evidence of teratogenesis in at least one laboratory animal" would trigger the cut-off criterion 10 . No remark is made, however, on exemption if the mode of action is shown not to be relevant to humans. The proposed rules for triggering a cut-off criterion for hormonal actions are even more drastic. ANVISA proposes that any hormonal disturbance, irrespective of being reversible or irreversible upon treatment discontinuation, would trigger the cut-off criterion for hormonal action 10 . Again no remark is made on relevance to humans. It also remains unclear what is to be considered an adverse effect resulting from a reversible hormonal disturbance.
Brazil has become the world's largest consumer of agricultural pesticides and there has been growing concern about the adverse health consequences of uncontrolled and careless use of such products in some rural areas. The time has come to move from cut-off criteria based purely on hazard to risk assessment, which is a more rational, reliable, fl awless, and effective approach to health risk management purposes.
Any amendment to a Federal law (Pesticide Law), however, has to be discussed and approved by the parliament before being enforced. A cut-off approach based primarily on hazard but also incorporating "negligible exposure" as an exemption -as adopted by EU -is an alternative that does not require changing the Pesticide Law. It can be put into effect by a lower ranking regulation issued by the health authority (ANVISA).
Along this line, Brazil would also greatly benefi t from taking advantage of GHS hazard categories 1A and 1B 27 as cut-off criteria for mutagenicity and carcinogenicity. The potential to induce malformations ("teratogenicity") is part of a more comprehensive GHS category ("toxicity for reproduction") and thus it is needed to redefi ne 1A and 1B categories for this particular hazard-based cut-off criterion. As far as hormonal actions are concerned, however, the current rules (SNVS regulation No. 3, January 16 th , 1992) 6 make more sense than those proposed by ANVISA in January 2011 10 . According to the current rules, a cut-off for hormonal actions is triggered if "no observed adverse effect levels remains undetermined"
and "the effect is not reversible" upon discontinuation of exposure, whereas the proposed new rules do not make an exception to the existence of an experimentally determined NOAEL (no observed adverse effect level) and triggers the cut-off even if hormonal changes are reversible. Reversible hormonal alterations are not necessarily harmful and experimentally derived NOAELs are reliable tools that can be used by regulators to manage health risks. As reminds us one of the most fundamental concepts of the modern science of toxicology, foreseen by Paracelsus nearly 500 years ago, the dose (exposure) "makes a substance not a poison".
